Aequus Pharmaceuticals Inc. (AQSZF)
OTCMKTS · Delayed Price · Currency is USD
0.0034
0.00 (0.00%)
At close: Sep 5, 2025
Aequus Pharmaceuticals Revenue
Aequus Pharmaceuticals had revenue of 218.22K CAD in the quarter ending June 30, 2025, with 35.19% growth. This brings the company's revenue in the last twelve months to 815.03K, up 192.96% year-over-year. In the year 2024, Aequus Pharmaceuticals had annual revenue of 584.24K with 129.21% growth.
Revenue (ttm)
815.03K CAD
Revenue Growth
+192.96%
P/S Ratio
0.80
Revenue / Employee
67.92K CAD
Employees
12
Market Cap
478.54K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 584.24K | 329.34K | 129.21% |
Dec 31, 2023 | 254.90K | -1.12M | -81.53% |
Dec 31, 2022 | 1.38M | -1.33M | -49.17% |
Dec 31, 2021 | 2.71M | 122.09K | 4.71% |
Dec 31, 2020 | 2.59M | 960.09K | 58.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
Aequus Pharmaceuticals News
- 4 months ago - Aequus Pharmaceuticals announces sale of Zimed PF to Luvo Medical Technologies - Seeking Alpha
- 4 months ago - Aequus Announces Sale of Zimed PF to Luvo Medical Technologies - TheNewswire
- 4 months ago - Aequus Pharmaceuticals reports Q1 results - Seeking Alpha
- 4 months ago - Aequus Reports First Quarter 2025 Financial Highlights - TheNewswire
- 10 months ago - Aequus Pharmaceuticals reports Q3 results - Seeking Alpha
- 2 years ago - Aequus Reports Second Quarter 2023 Financial Highlights and General Update - GlobeNewsWire
- 2 years ago - Aequus Announces Zimed PF Now Available in Canada - GlobeNewsWire
- 2 years ago - Aequus Announces Zimed PF Website Launch - GlobeNewsWire